ArticleDiabetes, obesity & metabolism2024

Semaglutide use in people with obesity and type 2 diabetes from real-world utilization data: An analysis of the All of US Program.

Craig S Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.